CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid. The company also offers anesthesia services for patients undergoing endoscopic procedures. It distributes the CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to gastroenterology practices. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada.
Industry, Sector and Symbol
Stock Exchange NYSEAMERICAN
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
SymbolNYSEAMERICAN:CRHM
CUSIPN/A
Phone+1-604-6331440
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding Shares72,850,000
Market Cap$229.48
CRH Medical (NYSEAMERICAN:CRHM) Frequently Asked Questions
What is CRH Medical's stock symbol?
CRH Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CRHM."
How were CRH Medical's earnings last quarter?
CRH Medical Corp (NYSEAMERICAN:CRHM) released its quarterly earnings results on Monday, April, 30th. The company reported $0.02 EPS for the quarter, beating analysts' consensus estimates of ($0.01) by $0.03. The business had revenue of $24.67 million for the quarter, compared to the consensus estimate of $21.70 million. View CRH Medical's Earnings History.
When is CRH Medical's next earnings date?
What price target have analysts set for CRHM?
7 analysts have issued 1 year price objectives for CRH Medical's shares. Their forecasts range from $5.00 to $5.00. On average, they anticipate CRH Medical's stock price to reach $5.00 in the next twelve months. This suggests a possible upside of 61.3% from the stock's current price. View Analyst Ratings for CRH Medical.
What is the consensus analysts' recommendation for CRH Medical?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CRH Medical in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
Are investors shorting CRH Medical?
CRH Medical saw a decline in short interest in the month of June. As of June 29th, there was short interest totalling 131,994 shares, a decline of 56.8% from the June 15th total of 305,717 shares. Based on an average daily trading volume, of 24,493 shares, the short-interest ratio is presently 5.4 days. View CRH Medical's Current Options Chain.
Who are some of CRH Medical's key competitors?
Some companies that are related to CRH Medical include Advanced Medical Solutions (AMS), TransEnterix (TRXC), CRH Medical (CRH), Tristel (TSTL), TSO3 (TOS), Clover (CLV), Bovie Medical (BVX), InfuSystem (INFU), Retractable Technologies (RVP), Milestone Scientific (MLSS), IsoRay (ISR), Akers Biosciences (AKR), Daxor (DXR), Omega Diagnostics Group (ODX) and Relevium Technologies (RLV).
Who are CRH Medical's key executives?
CRH Medical's management team includes the folowing people:
- Mr. Edward Wright, CEO & Non-Independent Director (Age 55)
- Mr. Richard K. Bear, CFO & Corp. Sec. (Age 55)
- Mr. James Kreger, Pres of CRH Anesthesia Management
- Ms. Kettina Cordero, Director of Investor Relations
- Dr. Mitchel Guttenplan M.D., FACS, Medical Director
Has CRH Medical been receiving favorable news coverage?
News headlines about CRHM stock have trended positive this week, according to Accern Sentiment Analysis. The research group identifies positive and negative press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. CRH Medical earned a coverage optimism score of 0.32 on Accern's scale. They also gave media stories about the company an impact score of 46.79 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days.
How do I buy shares of CRH Medical?
Shares of CRHM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CRH Medical's stock price today?
One share of CRHM stock can currently be purchased for approximately $3.10.
How big of a company is CRH Medical?
CRH Medical has a market capitalization of $229.48 million.
How can I contact CRH Medical?
CRH Medical's mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company can be reached via phone at +1-604-6331440.
MarketBeat Community Rating for CRH Medical (NYSEAMERICAN CRHM)
MarketBeat's community ratings are surveys of what our community members think about CRH Medical and other stocks. Vote "Outperform" if you believe CRHM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRHM will underperform the S&P 500 over the long term. You may vote once every thirty days.
